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Background: The study of a production chain of raw milk cheeses (St Marcellin, Vercors area, France) led to the
isolation of two Bifidobacterium populations: B. crudilactis and B. mongoliense, that were able to grow along the
production chain. The aims of this study were to further detect and characterize these bacteria along the process
and evaluate the ability of some strains to survive or grow in adverse conditions.
Results: Using PCR coupled with restriction fragment length polymorphism, B. crudilactis and B. mongoliense
were detected in respectively 77% and 30% of St Marcellin cheeses from production chain after 21 days of ripening.
They were present in more than half of all analyzed retail cheeses with counts going from 1.6 to 5 log cfu g-1 for
B. crudilactis and 1.4 to 7 log cfu g-1 for B. mongoliense. Bifidobacterium mongoliense was sensitive to pH 2, with an
observed decrease of at least 3 log for both studied strains (FR49/f/2 and FR41/2) after 1 h incubation. At pH 3, no
significant decrease was observed. Good survival was observed for the same strains in presence of pancreatic juice
with a decrease of less than one log. Survival of strain FR49/f/2 was better than FR41/2 with a decrease of 3
logarithms (in presence of 1% bile salts) and almost 2 logarithms (in presence of 0.5% bile salts). The genotypic
analyses using total DNA-DNA hybridization, GC% content, 16S rRNA gene sequencing and multilocus sequencing
analysis (MLSA) confirmed the classification of Bifidobacterium. crudilactis and B. mongoliense into two different
clusters well separated from other bifidobacteria clusters.
Conclusions: According to the observed characteristics such as survival in adverse conditions and their ability
to grow under 12°C during the manufacturing process of the cheeses, which has never been described for
bifidobacteria and which is a very interesting technological asset, these B. crudilactis and B. mongoliense strains
should be further investigated for a potential use in new food or in food supplements.
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The contamination of raw milk cheese production
chains, using bifidobacteria as fecal indicators, was
previously studied in two different cheese processes
in France [1]. It has been demonstrated in that study
that the species Bifidobacterium pseudolongum was
an efficient indicator of fecal contamination from
animal origin, since this species is predominant in
cow feces and has never been isolated in human
feces. In addition, as an indicator, B. pseudolongum
was more sensitive than E. coli along the two different
cheeses processes.
On the other side, bifidobacteria are also bacteria that
are often desired in food products for their technological
properties as thickening and stabilizing agents or for
their health promoting effects. For these reasons,
bifidobacteria and lactic acid bacteria are commonly
added to fermented food such as fermented milk or
yoghurt but also in food supplements. The positive
effects encountered with bifidobacteria can be miti-
gated by the difficulty of some strains or species to
resist or adapt to an industrial process. They prefer to
grow in the absence of oxygen, which can be a chal-
lenge in industry. In addition, some strains are not
able to survive the adverse conditions found in the
stomach and duodenum making it difficult to exert
any positive effect on the host.
The previous study of a production chain of L’Etoile
du Vercors (St Marcellin cheese produced from raw
cow’s milk, Vercors area, France) showed an increase of
total bifidobacteria along the process and led to the
isolation of two other Bifidobacterium populations, B.
crudilactis and B. mongoliense [2,3]. These populations
were able to grow along the cheese production chain.
The description of the species B. crudilactis was based
on one of those populations [4]. The other population
could be phylogenetically identified as B. mongoliense
[5] that was recently described based on two isolates
obtained from a traditional fermented mare’s milk in
Mongolia.
The aims of the study were (i) to further detect the
two bifidobacteria populations along the L’Etoile du
Vercors cheese production chain using 16S rDNA-
Restriction Fragment Length Polymorphism, (ii) to
evaluate the potential of B. mongoliense as a new food
supplement or as a potential new probiotic by the
study of several phenotypic characteristics such as
sugar fermentation profile, growth temperature profile
and aptitude to survive in adverse condition such as
acidic environment or environment rich in bile salts
and (iii) to perform a genotypic classification using
DNA-DNA hybridization and MLSA (Multilocus Se-
quencing Analysis) to identify if those new populations
belong to specific clusters.Results
Validation of the PCR-RFLP method on pure isolates of
bifidobacteria
Sixty-four strains belonging to 13 different species were
already tested in a previous study using PCR-RFLP [6].
Eight additional strains of Bifidobacterium crudilactis
and four French isolates identified as B. mongoliense
were analyzed in this part of the work (Table 1). The
RFLP patterns observed (i) with AluI was named V (5-
95-152-206-285-311 bp), (ii) with TaqI were called IX
(120- 210-250-470 bp) or X (132-200-664 bp). The patterns
combination V-X was attributed to B. crudilactis while
the V-IX combination was observed for B. mongoliense.
Detection of Bifidobacterium crudilactis and B. mongoliense
in the L’Etoile du Vercors cheese process and in
commercialized cheeses
- L’Etoile du Vercors cheese process (Table 2).
Out of the 176 samples from the L’Etoile du Vercors
cheese process (44 samples at each step of the process:
A-raw milk, B-after addition of rennet, C-after removal
from the mold, D-ripening) analyzed by PCR-RFLP, 108
(61%) were V-X type positive (B. crudilactis) and 31 (18%)
were V-IX type (B. mongoliense) positive. Their average
counts were respectively 2.27 ± 0.48 and 0.48 ± 0.7 log
cfu ml-1.
Bifidobacterium crudilactis was detected in 82% (step
A) and 77% (steps B and D) of the samples, but in only
9% of the samples at step C. The species B. mongoliense
was detected in only 18% of the total samples (31/176
samples). As observed for B. crudilactis, a very low
percentage of samples were positive at step C (2%), while
the highest percentage was found at stage D (30%).
The mean counts of B. crudilactis and of B. mongoliense
were studied at each step of the production chain (Table 2).
The B. crudilactis species presented highly significant
variations (p < 0.0005). A marked decrease at step C (0.30
log cfu ml-1) was followed by a high increase at step D
(3.45 log cfu ml-1). The mean counts of B. mongoliense
were low (less than 1 log cfu ml-1 or g-1) at the different
steps of the production chain (A, 0.61; B, 0.46; C, 0.00;
D, 0.86).
- Commercialized raw milk cheeses (Table 3).
Thirteen commercialized raw milk cheeses were ana-
lyzed: five trade cheeses from the plant in Vercors and
eight other trade raw milk cheeses with a manufacturing
process similar to the one in Vercors (Table 3).
Bifidobacterium crudilactis was detected in four St
Marcellin cheeses from the Vercors’ plant (Day 40),
with counts equal to 4 log cfu g-1 in two samples and 5
log cfu g-1 in the two others, but not in the Picodon
cheese from this plant. B. mongoliense was detected in
four cheeses out of five from this plant. This species
was found in the Picodon cheese (7 log cfu g-1) and in
Table 1 References and tests performed on all the strains analyzed in this study
Strains Performed tests
Species/collection
and reference nr
PCR-RFLP Acidification and enzymatic tests DNA-DNA relatedness MLSA In vitro resistance to gastric
acid, bile salts and pancreatic juice
B. mongoliense +
DSM 21395T
B. mongoliense + + + + +
FR49/f/2
B. mongoliense + +
MarV3/22
B. mongoliense + + +
FR39/1
B. mongoliense + +
MarV4/2
B. mongoliense + +
FR101/h/8;
B. mongoliense + +
MarV1/5
B. mongoliense + + +
FR66/e/1
B. mongoliense + +
MarC1/13
B. mongoliense + +
MarF/3
B. mongoliense + +
PicD/1
B. mongoliense + +
FR70/g/2
B. mongoliense + +
FR47/2
B. mongoliense + + + + +
FR41/2
B. crudilactis + +
FR35/5
B. crudilactis + + +
FR47/3
B. crudilactis + + +
FR50/f/4
B. crudilactis +
FR51/h/1
B. crudilactis +
FR54/e/1
B. crudilactis + +
FR55/d/2
B. crudilactis +
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Table 1 References and tests performed on all the strains analyzed in this study (Continued)
FR57/h/4
B. crudilactis + + +
FR59/b/2
B. crudilactis +
FR60/h/1
B. crudilactis + +
FR98/a/11
B. crudilactis + +
Brie/9
B. crudilactis + +
PicV/10
B. crudilactis + +
Reb/13
B. crudilactis + + + +
FR62/b/3
= LMG 23609T
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6 log cfu g-1 in the third).
In the eight other commercialized cheeses manufactured
with a similar process to the one in Vercors, B. crudilactis
was isolated from only three cheeses (mean count of 1.6
log cfu g-1) while B. mongoliense was isolated from five
cheeses (mean count of 1.4 log cfu g-1), including one
cheese made with pasteurized milk (2 log cfu g-1).
Phenotypic and genotypic characterization of
Bifidobacterium crudilactis and B. mongoliense strains
isolated from the cheeses
The species Bifidobacterium crudilactis was described by
[4] on the basis of 10 strains out of 141 isolates from
raw milk and two raw milk cheese production chains. Of
the 141 isolates, one hundred and thirty-seven were
obtained from 34 raw milk cheeses produced in the same
French raw milk cheese factory in the Vercors area, from
April 2003 to February 2004 [4]. Another isolate was taken
from a raw milk sample in another French raw milkTable 2 Number of positive samples (percentage) and mean c
Bifidobacterium crudilactis and B. mongoliense in the L’Etoile
production steps
Species RFLP types Production s
Total A
n = 176 n = 44/
B. crudilactis V-X 108 (61%)/ 36 (82%
2.27 ± 0.48 2.69 ± 1
B. mongoliense V-IX 31 (18%)/ 10 (23%
0.48 ± 0.7 0.61 ± 1
Production steps: A, raw milk; B, after addition of rennet; C, after removal from thecheese factory in the Courtenay area. The three remaining
isolates came from three commercialized French raw milk
cheeses (Picodon, Brie and Reblochon).
The description of Bifidobacterium mongoliense [5]
was based on the study of two strains isolated from a
traditional mare’s milk product from Mongolia. All
strains analyzed in this study are presented in Table 1.
Using thirteen B. mongoliense strains isolated from
French raw milk cheeses a more complete description of
the species was made. Six of these strains were isolated
from six raw milk cheeses at different steps of Vercors’
plant (FR41/2 in raw milk; FR39/1 and FR47/2 after
addition of rennet; FR66/e/1 after removal from the
mold; FR49/f/2 during ripening at day 15; FR70/g/2 at
day 21). Three strains (MarV1/5, MarV4/2 and MarV3/
22) were obtained from three commercialized cheeses
from the Vercors’ factory (day 40). One strain (FR101/h/8)
came from a raw milk cheese sample during ripening at
day 45 in another French raw milk cheese factory in
the Courtenay area, and three others (MarC1/13, MarF/3ounts (MC; log cfu ml-1 ± standard deviation) containing
du Vercors cheese process at the different
teps (% positive samples/mean counts (log cfu ml-1)
B C D
MC n = 44/MC n = 44/MC n = 44MC
)/ 34 (77%)/ 4 (9%)/ 34 (77%)/
.57 2.63 ± 1.43 0.30 ± 1.02 3.45 ± 2.18
)/ 7 (16%)/ 1 (2%)/ 13 (30%)/
.1 0.46 ± 1.1 0.0 ± 0.0 O.86 ± 1.7
mold; D, ripening (D 21); n = number of cheese sample.
Table 3 Number of positive samples and mean counts (log cfu ml-1 or g-1 ± standard deviation) of Bifidobacterium
crudilactis and B. mongoliense in 5 trade St Marcellin cheeses and of 8 other trade raw milk cheeses
Species Retail St Marcellin (5) Retail others* (8)
(number of positive) log cfu ml-1 or g-1 (number of positive) log cfu ml-1 or g-1
B. crudilactis (4/5) 3.6 ± 2.07 (3/8) 1.6 ± 2.27
B. mongoliense (4/5) 4.6 ± 2.70 (5/8) 1.4 ± 1.51
*, Other retail cheese with a manufacturing process similar to the one in Vercors (Picodon, Brie and Reblochon).
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cheeses (Picodon and Saint-Marcellin). All cheeses
containing B. crudilactis and B. mongoliense strains
were made from raw cow milk, except for the two
Picodon cheeses, which were made from raw goat milk.
The strain FR41/2 was retained as representative of
the B. mongoliense French isolates since it was pheno-
typically the closest to all other French isolates.Phenotypic characterization
The major differential characteristics between the
species Bifidobacterium crudilactis, B. mongoliense,Table 4 Phenotypic characteristics allowing differentiation be
during this study and the type strain DSM 21395T), B. crudila
B. psychraerophilum LMG 21775T
Characteristics BM BM BC
(13 strains,
% positive responses)
DSM 21395T [5] (9 st
resp
Acidification of :
L-arabinose 100 + 0
D-xylose 0 - 10
α-methyl-D-mannoside 0 - 0
N-acetylglu-cosamine 0 - 0
Salicin 85 + 20
Lactose 100 + 100
melezitose 0 - 10
Glycogen 92 + 10
Enzymatic tests :
α-arabinosi-dase 100 NT 0
glycine arylamidase 38 NT 100
Growth temperature
range
10°Ca-41°Cb 15°C-40°C 5°C-
Minimum growth pHc NT
DNA G + C content
(mol%)
61.1 (6 strains) (SD =
0.67)
61.1 55.2
Legend of Table 4: BM: B. mongoliense, BC: B. crudilactis, BP: B. psychraerophilum; a,
experiments performed in the laboratory; NT, not tested. Other phenotypic characte
strains of ribose, galactose, glucose, esculin, cellobiose, maltose, melibiose and raffi
β-glucosidase, arginine arylamidase, proline arylamidase, phenylalanine arylamidase
ferment glycerol, erythritol, D-arabinose, L-xylose, adonitol, β-methyl-xyloside, L-sor
D-tagatose, D-fucose, L-fucose, D-arabitol, L-arabitol, gluconate, 2-keto-gluconate, 5
indole production, nitrate reduction, arginine dihydrolase, β-galactosidase-6-phosph
decarboxylase, α-fucosidase, acide pyroglutamique arylamidase, glutamyl arylamidaand the type strain of B. psychraerophilum are presented
in Table 4.
Bifidobacterium psychraerophilum is one of the genetic-
ally closest species also able to multiply at low tempera-
tures. The 13 French strains identified as B. mongoliense
were able to multiply from 10°C within 14 days to 41°C
within 8 days. The FR41/2 strain, representative of the 13
strains, is also able to form colonies on TPY agar under
aerobic conditions at 37°C within 3 days. The colonies
reach a reduced diameter under aerobic conditions
compared to the diameter, up to 1 mm, observed after
3 days under anaerobic conditions. In TPY, the minimum
initial pH for growth of FR41/2 was 4.7 within 48 h (weaktween Bifidobacterium mongoliense (13 strains isolated
ctis (10 strains, including the type strain) and
BC BP
rains, % positive
onses; [4]
LMG 23609T [4] LMG 21775T [27]
- +
- +
- +
- +
- +
+ -
- +
- -
- +
+ +
45°C 4°C-45°C 4°C-42°C
4.5
(9 strains) (SD = 0.83) 56.4 (4 exper.) (SD =
0.60)
59.2 (HPLC, Simpson
et al., 2004) 55.7 (Tm
d )
growth within 14 days; b, within 8 days; c, within 48 h; d, mean of 2
ristics of the French B. mongoliense strains: acidification by ≥ 90% of the
nose and were positive for α-galactosidase, β-galactosidase, α-glucosidase,
, tyrosine arylamidase and histidine arylamidase. None (≤ 10% of the strains)
bose, rhamnose, dulcitol, inositol, mannitol, sorbitol, inulin, xylitol, D-lyxose,
-keto-gluconate. All strains (≤ 10% of the strains) were negative for urease,
ate, β-glucuronidase, β-N-acetylglucosaminidase, acide glutamique
se.
Delcenserie et al. BMC Microbiology 2013, 13:239 Page 6 of 13
http://www.biomedcentral.com/1471-2180/13/239growth observed at pH 4.4 and no growth at pH 3.8 within
15 days).
Similar growth characteristics were observed by [5]
except that no growth of B. mongoliense YIT 10443T
occurred at 10°C, nor at 40°C.
Resistance to gastric, pancreatic juices and bile salts of
Bifidobacterium mongoliense strains FR 49/F/2 and
FR41/2
Gastric juice
At pH 2, a decrease of at least 3 log was observed for both
studied strains after 1 h of incubation. At pH 3, a good
survival of both strains was observed, even after 5 h of
incubation, with no significant decrease in bifidobacteria
counts (Table 5).
Pancreatic juice
Both strains had a good survival in the presence of
pancreatic juice (pH 8, Table 5). A slight decrease was
observed for both of them. The strain FR49/f/2 presented
a decrease of respectively 0.44, 0.46, 0.46 and 0.50 log
after 2 h, 3 h, 4 h and 5 h. The strain FR41/2 presented
a decrease of 0.41 log after 5 h.
Bile salts
In presence of a concentration of 1% bile salts, a decrease
of 3.39 and 4.11 log was respectively observed for the
strains FR49/f/2 and FR41/2 after 48 h. The strain FR49/f/
2 was less sensitive to lower bile salts concentration
with a decrease of 3.07 log and 1.76 log in presence of
bile salts at a concentration of respectively 0.5% and 0.3%.
The sensitivity of the strain FR41/2 to lower bile salts
concentration was the same than in presence of 1% with aTable 5 Resistance to biological barriers for Bifidobacterium m
Strains Incubation
time
Resistance to gastric juicea Resistan
pH 2 pH 3 pH 8
FR49/f/2 T1 h > 3 log 0.02 ± 0.6
T2 h > 3 log 0.05 ± 0.6
T3 h > 3 log 0.05 ± 0.6
T4 h > 3 log 0.16 ± 0.6
T5 h > 3 log 0.04 ± 0.7
T48 h NA NA NA
FR41/2 T1 h > 3 log −0.04 ± 0.7
T2 h > 3 log 0.11 ± 0.8
T3 h > 3 log 0.29 ± 0.7
T4 h > 3 log 0.51 ± 0.6
T5 h > 3 log 0.61 ± 0.7
T48 h NA NA
Decrease in viable cell counts (log CFU ml-1) after exposure: ato low pH (2 and 3) so
cto bile salts (1, 0.5 and 0.3% ) during 48 h at 37°C.
NA: not applicable.
ND: not determined.decrease of 3.93 log and 4.14 log with a concentration of
bile salts of respectively 0.5% and 0.3% (Table 5).
Genotypic characteristics
All data concerning Bifidobacterium crudilactis (phylogen-
etic relationships, guanine plus cytosine content, DNA-
DNA relatedness) were given by [4].
The 16S rDNA sequences of B. mongoliense strains
FR41/2T, FR49/f/2, and FR101/h/8 were continuous
stretches of 1452 bp respectively (Accession numbers:
HV688664, HV688665, HV688666). There was 100%
identity between these sequences after alignment with
ClustalX [7], and a high phylogenetic relationship (99.9%)
between the 16S rRNA gene sequence of FR41/2 and that
of B. mongoliense YIT 10443T.
The DNA G +C content of the representative strain
FR41/2 was 60.5% (average of two experiments, SD = 0.71).
The average DNA G + C content of six strains in the
group was 61.1% (SD = 0.67), which is also the G + C
content of the B. mongoliense type strain (YIT 10443T).
Those values were higher than the G + C contents of B.
psychraerophilum LMG 21775T (55.7%) and B. crudilactis
LMG 23609T (56.4%), using the Tm method. However,
similar DNA G + C contents are found with the same
method in the genus Bifidobacterium, for the species
B. cuniculi, B. gallinarum, B. pseudolongum subsp.
pseudolongum, B. pseudolongum subsp. globosum and
B. scardovii [8].
DNA-DNA hybridizations were performed with DNAs
of FR41/2, other French B. mongoliense isolates and the
type strains of B. mongoliense, B. minimum and B. subtile,
the closest phylogenetically related species (Table 6). The
DNA-DNA relatedness (%) between B. mongoliense DSMongoliense strains FR 49/F/2 and FR 41/2
ce to pancreatic juiceb Resistance to bile saltsc
1% 0.5% 0.3%
0.13 ± 0.35 ND ND ND
0.44 ± 0.05 ND ND ND
0.46 ± 0.03 ND ND ND
0.46 ± 0.06 ND ND ND
0.50 ± 0.07 ND ND ND
3.39 ± 0.34 3.07 ± 0.25 1.76 ± 0.13
0.06 ± 0.09 ND ND ND
0.06 ± 0.06 ND ND ND
0.01 ± 0.15 ND ND ND
0.02 ± 0.10 ND ND ND
0.41 ± 0.24 ND ND ND
4.11 ± 0.00 3.93 ± 0.00 4.14 ± 0.00
lutions during 1-5 h at 37°C, bto pancreatic juice solution during 1-5 h at 37°C,
Table 6 DNA-DNA relatedness (%) between DNAs of
FR41/2 and other French Bifidobacterium mongoliense
strains, and between FR41/2 and the type strains of B.
mongoliense, B. minimum and B subtile
Species/collection and
reference no.
DNA-DNA relatedness
with FR41/2
B. mongoliense DSM 21395T 95
B. mongoliense FR49/f/2; MarV3/22 100
B. mongoliense FR39/1 95
B. mongoliense MarV4/2 94
B. mongoliense FR101/h/8; MarV1/5 93
B. mongoliense FR66/e/1 92
B. mongoliense MarC1/13 89
B. mongoliense MarF/3 88
B. mongoliense PicD/1 86
B. mongoliense FR70/g/2 84
B. mongoliense FR47/2 80
B. minimum DSM 20102T 8
B. subtile DSM 20096T 15
Legend of Table 6: DSMZ, Deutsche Sammlung von Mikroorganismen und
Zellkulturen GmbH, Göttingen, Germany. The strain Bifidobacterium
mongoliense (YIT 10443) was deposited in the DSMZ by Dr. Koichi Watanabe,
Yakult Central Institute for Microbial Research, 1796, Yaho, Kunitachi, Tokyo
186–8650, Japan.
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French isolates (80% to 100%) confirmed identification of
these isolates as B. mongoliense. Strain FR41/2 showed low
DNA-DNA similarity to the type strains of B. minimum
and B. subtile (Table 6).
Strains clustering using a multilocus approach
Analysis of MLSA (Multilocus Sequencing Analysis)
results of B. mongoliense FR41/2 and FR49/f/2 and B.
crudilactis FR62/b/3T, based on concatenated sequences
of the housekeeping genes clpC, fusA, gyrB, ileS, purF, rplB
and rpoB, revealed a cluster for these strains, that was
separated from other Bifidobacterium strains from the
MLST and NCBI database (Figure 1). An allelic profile
was determined for the 3 strains (Table 7), according to
the method of [9] and was compared to the allelic profile
of previously studied strains [9]. The same sequence type
was observed for the strains FR41/2 and FR49/f/2. There
were different by only one nucleic acid for the allele purF
and rplB.
Discussion
It appears from our results that the species Bifidobacterium
crudilactis and B. mongoliense are commonly present in St-
Marcellin and other cheeses having a similar manufacturing
process such as Picodon, Camembert, Brie and Reblochon.
B. crudilactis and B. mongoliense were detected in respect-
ively 77% and 30% of cheeses from L’Etoile duVercors plantafter 21 days of ripening. In addition, they were present in
more than half of analyzed retail cheeses. Their presence
and their source are not explained yet but they probably
contribute to organoleptic and technologic properties of
those cheeses.
During the L’Etoile du Vercors cheese process, a very
low percentage of samples were positive at step C (after
removal from the mold, day 2) with respectively 9% and
2% of positive samples for Bifidobacterium crudilactis and
B. mongoliense. An explanation for the low percentage
could be the presence of competitive flora at this stage
associated with a low pH (4.35 at step C). However,
during ripening (step D), the conditions seemed more
favorable for those species with respectively 77% and 30%
of positive samples for B. crudilactis and B. mongoliense.
The ripening temperature, 12°C, used in the Vercors
factory enables these species to grow along the production
chain. B. crudilactis was isolated at higher levels (mean
count 3.45 log cfu g-1 at step D) than B. mongoliense in
the Vercors’ factory. These levels were still higher in the
four commercialized St Marcellin cheeses (D40, mean
count 4.5 log cfu g-1).
Bifidobacterium mongoliense was detected in only 30%
of the samples during ripening of the Vercors’ production
chain (mean count 0.86 log cfu g-1 at step D) but was
present at much higher levels in three of the commercial-
ized St Marcellin cheeses (5 to 6 log cfu g-1) and in the
Picodon cheese made with goat raw milk (7 log cfu g-1)
from the Vercors area. These results suggest that both
species, when present along the chain, continue to multi-
ply in the cheeses after production, during storage.
B. mongoliense was detected in one cheese made from
pasteurized milk. The most probable explanation is a cross
contamination along the process or commercialization
leading to the presence of this bacterial species. Inter-
estingly, the other species, B. crudilactis was detected
in thermized milk in our study (St Marcellin Cholet)
and in thermized milk from Canada [10]. This suggests
that B. crudilactis has the potential to resist to some heat
treatment. Those properties should be better investigated,
as they are important when these bacteria are incorpo-
rated in food products where heating steps are present.
The resistance to gastric and pancreatic juices, and bile
salts of these bifidobacteria encourages further study for
their potential to survive the transit through the human
intestinal tract. The stomach normally produces around
2.5 l of HCl per day at a pH of 2.0 and a stomach pH
can drop as low as 1.5 [11]. It is therefore important,
when selecting probiotic strains candidates, to choose
strains able to survive this barrier. Usually, acid resistance
of probiotic strains is estimated for different pH values
ranging from 1.5 to 5.0. Incubation time can vary from
1 to 360 minutes at 37°C, according to the fact that
food usually remains in the stomach for about 90 minutes.
Figure 1 Concatenated tree obtained by MLSA (Multilocus sequence analysis). Phylogenetic analysis was performed based on the
concatenated sequences of seven genes using the bioinformatics software “Geneious” (http://www.geneious.com).
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FR41/2 was observed in gastric juice at pH = 2, after
1 h of incubation. However, the survival of the strains was
excellent at pH 3. Those results are quite encouraging
knowing the limitation of the used method, namely HCl
acidified media do not take into account the influence
of diet or non-acidic gastric constituents on the micro-
organisms during their gastric transit making that test
usually too severe. For example, the strain Lactobacillus
GG cannot survive in static models, but is able to reach
colon in high number in vivo [12,13]. The strains assessed
in our study should be further tested in a dynamic in vitromodel such as the SHIME or M-SHIME system [14,15]
for confirmation of their survival through the transit.
Pancreatic secretions are amongst the most aggressive
fluids in the human body. In our case, using a commercial
pancreatic solution at pH 8, a good resistance of both
strains was observed even after 5 h incubation.
Physiological concentrations of bile salts are between 0.3
[16] and 0.5% [17]. This is why bile solutions containing
bile salts at concentrations of 0.3, 0.5 and 1% were tested
in our study. Usually, bacteria are exposed to bile salts
from 3 to 96 h. Bile salts secretions in vivo are highly
variable and difficult to predict. In our study, the strain
Table 7 Sequence types of Bifidobacterium crudilactis and B. mongoliense
Strains Alleles Template size (bp) Results (Sequence type according to deletoile et al., 2010) Identity %
B. crudilactis FR/62/b/3 gyrB 600 46 79.27
fusA 666 33 80.63
purF 627 37 82.74
ileS 489 50 82.41
rplB 591 23 84.59
rpoB 357 1 84.03
clpC 501 33 83.42
B. mongoliense FR41/2 gyrB 600 46 80.22
fusA 666 10 90.77
purF 627 40 84.77
ileS 489 56 88.34
rplB 591 4 87.39
rpoB 357 1 85.83
clpC 501 9 85.24
B. mongoliense FR49/f/2 gyrB 600 46 80.22
fusA 666 10 90.77
purF 627 40 84.6
ileS 489 56 88.34
rplB 591 4 87.68
rpoB 357 1 85.63
clpC 501 9 85.24
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with 0.3% bile salts. In the other conditions, a decrease of
approximately 3 logarithms was observed. It is important
to note that bile salts solutions and animal bile extracts
are more aggressive for bacteria than human bile [16].
According to the fact that human bile is not easily
available, testing of bile salts is a good compromise
even if the conditions tested are probably more aggressive
than in reality. The best compromise would have been to
use bovine bile extract, which is less toxic than bile salts,
but still more toxic than human bile.
The results obtained by MLSA are in accordance with
the other genomic data presented in this study and
allow a temporarily classification of B. crudilactis and
B. mongoliense in two different clusters, well separated
from the other bifidobacteria clusters. If, in the future,
additional genome sequences are available on public
database such as NCBI or on Bifidobacterium MLST (Mul-
tilocus sequence typing) database (Paris Institut Pasteur;
[9]), more closely related Bifidobacterium species such as
B. bohemicum, B. minimum, and B. psychraerophilum
could be included in this analysis as well. This method
was already successfully used for species identification in
several genera such as Vibrio or Bifidobacterium [18-21].
However, one of the next steps will be to continue the
genetic analysis of the full genome sequences to betterunderstand the evolution of those strains and be able to
explain their specific phylogenetic characteristics.
Origin of the species B. crudilactis and B. mongoliense
is not known. In a previous paper [1], B. pseudolongum
was chosen as an efficient fecal indicator since its mean
counts remained stable along both studied processes. In
addition, B. pseudolongum defined a contamination from
animal origin since this species is predominant in cow
dung and has never been isolated in human feces. In the
case of B. crudilactis and B. mongoliense, the fecal origin
is not demonstrated.
Conclusion
The species B. crudilactis and B. mongoliense were detected
in raw milk cheeses from the Vercors’ area. The origin
of these bacteria is not known yet, but their presence in
the cheeses probably contributes to specific organoleptic
and technologic characteristics of those cheeses. This
study allowed to report that these bacteria are able to
grow under 12°C during the manufacturing process of the
cheeses, which has never been described for bifidobacteria,
and which is a very interesting technological asset. In
addition, the bacteria were able to resist to low pH and
aggressive fluids such as pancreatic juice and biliar salts.
Because of the special characteristics of these bifidobac-
teria, further investigations should be performed to better
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effect as possible new probiotics. The genotypic analyses
using total DNA-DNA hybridization, GC% content, 16S
rRNA gene sequencing and MLSA further confirmed
the classification of B. crudilactis and B. mongoliense
into two different clusters, well separated from other
bifidobacteria clusters.
Methods
Samples from St Marcellin process (Vercors plant)
The manufacturing process was already described pre-
viously. Briefly, milk was collected on farms and stored
in tanks at the plant at 4°C as already described [22].
Next, the milk was prepared for maturation by addition
of cream, starter and surface flora. Temperature was
increased to 22°C. Animal rennet was added (Day 0). On
the next day (Day 1), the following steps were successively
performed: molding, a first manual turnover, a manual
salting and a second turnover. During that day, pH
decreased from 6.5 to 4.3 while temperature remained
stable (22°C). On the second day, cheeses were removed
from the molds and a new manual or mechanical salting
was performed. Ripening was then carried out for 28 days.
Temperature was 12°C from Day 8. During that stage, pH
slowly increased from 4.35 (at the beginning of ripening),
to 4.7 (Day 15), to 5.5 (Day 21), to more than 6 (Day 28).
Forty-four raw milk cheeses at 4 different steps (176
samples) were analyzed at the following production steps:
raw milk (Step A, Day 0), after addition of rennet (Step B,
Day 0), after removal from the mold (Step C, Day 2) and
during ripening (Step D, Day 21).
Commercialized cheeses samples
Thirteen raw milk cheeses from retail were analyzed.
Five were cheeses from L’Etoile du Vercors (St Marcellin,
4; Picodon/goat cheese, 1) collected at D + 40 to 43.
Eight were additional cheeses produced with a similar
process than the one of L’Etoile du Vercors’s company
(St Marcellin fermier, 1, St Marcellin made from thermized
milk « Cholet », 1, St Marcellin made from raw milk «
Cholet », 1, Picodon de la Drôme (goat cheese) « Scoff »,
1, Reblochon made from raw milk « Rochebrune », 1,
Camembert made from raw milk « Lepetit », 1, Brie de
Melun made from raw milk « St Faron », 1, Camembert
made from pasteurized milk « Bridel », 1).
PCR-RFLP
- Enrichment step.
The enrichment medium was carried on as described
previously [22] in supplemented Brain Heart Infusion
(BHI, 37 g l-1, Bio-Rad, Marnes-la-Coquette, France). One
ml of milk or 1 g of raw milk cheese was transferred into a
tube of 9 ml enrichment medium, and 1 ml of each of the
ten fold appropriate sample dilutions in quarter-strengthRinger solution containing cystein chlorhydrate (0.3 g l-1)
was also inoculated in tubes of enrichment medium in
order to detect bifidobacteria in milk and raw milk cheese
until the 10-6 dilution to get semi-quantitative counts as
described previously [1]. Estimated mean counts of bifido-
bacteria (log cfu g-1) were obtained after calculating the
averages of the last positives dilutions for which a value of
1 cfu ml-1 were attributed. Tubes were incubated at 37°C
for 72 h in aerobiosis, as the bacteria were able to grow in
depth because of the presence of agar in the medium.
- DNA extraction and PCR-RFLP protocol.
DNA for sequencing was extracted from culture broths
obtained after the enrichment step as described previously
[1] using the Wizard Genomic DNA purification kit
(Promega, Madisson, WI, USA) with addition of lysozyme
(10 mg/ml, Eurogentec, Seraing, Belgium).
The PCR method for the detection of the genus Bifido
bacterium consisted of primers targeting the 16S rRNA
gene followed by a digestion using 2 restriction enzymes
AluI and TaqI (Roche; Basel, Switzerland) for species
detection as described previously [6]. Twenty microliters
of the PCR product was restricted by 1U of enzyme in 1X
buffer at 37°C for 3 h with AluI and at 65°C for 3 h with
TaqI in a total volume of 30 μl. Following the digestion,
the products were analyzed by gel electrophoresis using
2.5% agarose gel. The profiles were analyzed using the
Kodak 1D software (Thermolabsystems, Brussels, Belgium).
Phenotypic characteristics
The F6PPK test was assayed on isolates as described
by [23], after cell disruption by sonication (Sonopuls
homogenizer HD-70, Bandelin, Berlin, Germany) for
30 sec. Bifidobacterium crudilactis and French B.
mongoliense strains were discriminated in a pheno-
typic numerical study using the unweighted pair group
method with averages (UPGMA, [24]). Phenotypic tests
were 49 carbohydrate fermentations, 30 enzymatic tests
performed on API 50CH and Rapid ID32A kits (Bio-
Mérieux-department API, La Balme les Grottes, France)
according to the manufacturer’s instructions. The ability
of the strains to grow at 46°C was performed in Tryptone
Phytone Yeast (TPY) broth within 48 h [4]. The levels of
similarity between strains were calculated using UPGMA
(Sneath et al. 1973), and the Jaccard index. The numerical
analysis included type strains of Bifidobacterium species
and Aeriscardovia aeriphila as described previously [24].
The range of temperature for the growth of Bifidobac
terium crudilactis and French B. mongoliense strains was
tested in TPY broth (in water bath) at 41°C, 41.5°C, 43°C,
44°C, 45°C, 46°C and 47°C for 8 days and at 4°C, 5°C,
6°C, 7°C, 8°C, 9°C, and 10°C for 14 days. All temperatures
were controlled using a temperature standard probe certi-
fied by the French Committee for Accreditation (COFRAC).
Growth of FR62/b/3T (B. crudilactis) and of FR41/2 (B.
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under aerobic and anaerobic conditions and at 39°C in
TPY broth at different pH values (3.8, 4.4 and 4.7). All
strains tested in this study are presented in Table 1.
Resistance to gastric, pancreatic juices and bile salts
Tolerance to acidic conditions and gastric juice:
To measure the resistance to gastric juice during digestion,
the method of [11] was followed. Briefly, the strains FR49/
f/2 and FR41/2 were grown anaerobically in MRS for 36 h
at 37°C. The pellets were collected by centrifugation at
4000 rpm and suspended in gastric juice solution (solution
of 0.3% pepsin w/v (Sigma-Aldrich, Bornem, Belgium) and
0.5% NaCl w/v) adjusted to pH2 or pH 3. The solutions
were incubated in anaerobic conditions during 5 h at 37°C.
Plate counts were performed every hour using an auto-
mated spiral plater (Don Whitley Scientific LTD., Shipley,
West Yorkshire, England). The results were compared to a
blank composed of the corresponding strain in suspension
in K2HPO4 buffer solution (pH 6.5) instead of gastric
juice solution.
Tolerance to pancreatic juice:
The resistance to pancreatic juice was measured as de-
scribed by [11]. Briefly, the strains FR49/f/2 and FR41/
2 were grown anaerobically in MRS for 36 h at 37°C.
The pellets were collected by centrifugation at 4000 rpm
and suspended in pancreatic juice solution (solution of 1 g
pancreatin (Sigma-Aldrich, Bornem, Belgium) in 1 l of
solution containing 0.5% NaCl w/v solution) adjusted
to pH 8 using 5 mM NaOH [11,25]. Every hour during
5 hours, the survival of bifidobacteria was estimated using
plate counts on MRS agar medium using an automated
spiral plater (Don Whitley Scientific LTD., Shipley, West
Yorkshire, England). The results were compared to a
blank composed of the corresponding strain in suspension
in K2HPO4 buffer solution (pH 6.5) instead of pancreatic
juice solution.
Tolerance to bile salts:
The resistance to bile salts was measured according to
the method of [26]. Briefly, the strains FR49/f/2 and
FR41/2 were inoculated in MRS supplemented with 0%,
0.3%, 0.5% and 1% of bile salts (LP0055, Oxoid). At T0
and after an incubation period of 48 h, plate counts were
performed to evaluate the survival of both strains under
the different bile salts concentrations. The results were
compared to the strains incubated in the media containing
0% of bile salts.
Genotypic characteristics
16S rRNA gene sequencing
The 16S rRNA gene of strains FR41/2, FR49/f/2 and of
FR101/h/8 was amplified and sequenced. Two 16S rDNAprimers [27] were used to generate a 1452-pb 16S rDNA
product. CO1 [28] was used for the 5′ end (5′ –
AGTTTGATCCTGGCTCAG - 3′) and CO2 [28] for
the 3′ end (5′ - TACCTTGTTACGACT - 3′). The PCRs
were performed in 100-μl (each) solution containing 2 mM
of each desoxynucleotide triphosphate (Eurogentec,
Seraing, Belgium), 1,5 mM MgCl2, 5% (vol/vol) DMSO,
10 × FastStart reaction buffer, 0,4 μM (each) primer, 10 μl
of DNA and 5 U of FastStart DNA polymerase (Roche
Diagnostics Belgium, Vilvoorde, Belgium). The amplifica-
tion was performed as previously described by Simpson
et al. (2004). PCR amplicons were purified using an
ExoSAP-ITW purification kit (USB Corporation, Ohio,
USA). The recovered rDNA was sequenced using 4 forward
primers: CO1 [27], Up1 (5′- AATAAGCACCGGCTAAC-
TACG -3′), Up2 (5′- AACGGTGGATGCTGGATGTG –
3′) and Up3 (5′ – CGGTACAACGAGATGCGAC – 3′),
and four reverse primers: CO2 [27], Rev1 (5′ – TCAGTC
CCAATGTGGCCG -3′), Rev2 (5′ – GTATCTAATCCTG
TTCGCTCCC -3′) and Rev3 (5′ – TCGAATTAATCCG
CATGCTC – 3′) as described previously [4]. The primers’
Up1, Up2, Up3, Rev1, Rev2 and Rev3 binding sites were
respectively at nucleotide numbers 402 to 422, 722 to
741, 1152 to 1170, 252 to 235, 702 to 681 and 872 to
853, within the 16S rRNA gene sequence of B. crudilactis
FR62/b/3 (AY952449). The sequencing reaction was carried
out after a purification step (AutoSeq G-50 (Amersham
Biosciences, Ohio, USA)) using a DYEnamic™ET dye
terminator cycle sequencing kit for MegaBace™ (Amersham
Biosciences, Ohio, USA).
The sequences were aligned with 16S rRNA gene
sequences of cultured bacteria. Sequences producing
significant alignments as determined by BLAST analysis
were Bifidobacterium mongoliense, B. psychraerophilum,
B. crudilactis and B. minimum (comparison based on
an alignment of 1452, 1428 pb, 1384 pb and 1416 pb
respectively).
Determination of DNA G + C content
The DNA G+C content were determined by the thermal
melting point method (Tm method, [29]) using a Cary 100
spectrophotometer connected to a Peltier temperature
controller (Varian, France).
DNA-DNA hybridizations
DNA-DNA hybridizations between DNA of FR41/2
and the type strain of B. mongoliense DSM 21395T were
performed at BCCM/LMG. DNA for these hybridizations
was extracted using the method described by [30], modi-
fied to a larger scale. The hybridizations were performed
in the presence of 50% formamide at 47.5°C according to
a modification [31,32] of the microplate method described
by [33]. Reciprocal reactions (A x B and B x A) were per-
formed, and the variation was within the limits described
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reported for this pair of DNA is the mean of minimum 7
hybridizations.
DNA-DNA hybridizations between DNA of FR41/2 and
the type strains of B. mongoliense, B. subtile and other
French B. mongoliense isolates were performed with DNA
extracted as described by [34], using achromopeptidase
(5,000 U/500 mg bacteria, Sigma, France) and lysozyme
(400,000 U/500 mg bacteria, MP Biomedicals, France)
as lytic enzymes. This DNA was fragmented at approxi-
mately 100 MPa using an Aminco French pressure cell
(Bioritech, France), and the degree of DNA-DNA related-
ness was quantified from renaturation rates according to
the method of [35], using a Cary 100 spectrophotometer
connected to a Peltier temperature controller (Varian,
France). The renaturation temperature was 25°C below
the midpoint (Tm) i.e. 67.3°C, according to the G + C
content of FR62/b/3T. DNA-DNA relatedness values were
calculated after 21 and 24 min of incubation. The first
3 min of renaturation, during which the temperature
stabilised, were excluded from calculations. Reassociation
percentages were 4 Vm – (Va +Vb) / 2 (Va × Vb)
½, where
Va,Vb and Vm were the decreases in absorbance at 260 nm
per min for organisms A and B and for an equal mixture
of the two.
Strains clustering using a multilocus approach
Three stains were analyzed using MLST (Multilocus
Sequencing Typing): B. crudilactis type strain FR62/b/
3T and two representative strains of B. mongoliense
(FR49/f/2 and FR41/2).
The strains were grown anaerobically at 37°C during
48 h in Brain Heart Infusion (BHI, Oxoid, Thermo Fisher
Scientific, Aalst, Belgium) supplemented with propionic
acid (5 ml/l), ferric citrate (0,5 g/l), cystein hydrochloride
(0,5 g/l), yeast extract (5 g/l) at pH 5. The following seven
housekeeping genes were chosen, based on their good
discriminatory power for bifidobacteria, as demonstrated
previously [9]: clpC, fusA, gyrB, ileS, purF, rplB and rpoB.
The sequences of the different alleles for each gene were
obtained after full genome sequencing of the three strains
and were concatenated (Sequences deposited on Genbank;
accession numbers: BankIt1591847 Seq1 KC527635 to
BankIt1591847 Seq21 KC527655).
In order to obtain sufficient quantity of DNA for
complete sequencing, the DNA extraction protocol of
[36] was used. The library has been sequenced on a
Roche FLX (1/8 plate) using Titanium chemistry (Roche
Diagnostics, Vilvoorde, Belgium). For each gene, the alleles
found in the genomes were compared to the alleles
sequences obtained from the Bifidobacterium MLST
(multilocus sequence typing) database (Paris Institut
Pasteur) available for the probiotic Bifidobacterium
species: B. bifidum, B. breve, B. longum subsp. animalisand B. longum subsp. longum [9] at http://www.pasteur.fr/
recherche/genopole/PF8/mlst/Bifidobacterium.html. This
public database allows queries and downloads of allele
sequences and allelic STs, provides several database
tools and statistics and is also open to additional data
on novel strains and species. The genomes of other
Bifidobacterium species were also available on NCBI (B.
angulatum DSM20098 (NZ_GG663536), B. catenulatum
DSM 16992 (NZ_ABXY01000031), B. dentium ATCC
27678 (ABIX02000002) and B. gallicum DSM 20093
(NZ_ABXB03000001)). Alleles from each gene were
selected using clustalW (http://www.ebi.ac.uk/) and con-
catenated. Next, the concatenated DNA sequences were
aligned and analysed using the bioinformatics software
“Geneious” (http://www.geneious.com/). Phylogenetic ana-
lysis was performed based on the concatenated sequences
of the seven genes on Geneious (Figure 1).
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